Pfizer 2011 Annual Review | Pfizer: the world's largest research-based pharmaceutical company
READ
THE CEO
LETTER

From Our CEO

Performance
Download Performance
(PDF)

Non-Financial Performance Highlights

We continue to track our progress against key areas of non-financial business performance. In addition to the metrics below, we have provided progress updates and additional metrics throughout the annual review.

Access to Medicine

17

Number of top 20 global burdens
of disease addressed by products
and pipeline1

10

Number of global programs and commercial transactions to increase access to medicines in emerging markets2

15

Number of emerging markets in which Pfizer has implemented intra-country tiered pricing3

Employees

0.59

INJURIES PER 100 EMPLOYEES

TOTAL INJURY RATE4
Pfizer has averaged 8% injury
rate reduction annually for the
past four years

Environment5

2.7

MILLION METRIC TONS CO2 EQ6

GREENHOUSE GAS EMISSIONS
Total GHG emissions in 2011
were 5% lower than 2010

54

MILLION CUBIC METERS7

WATER WITHDRAWAL
Total water withdrawal in 2011
was 12% lower than 2010

264

THOUSAND METRIC TONS8

WASTE GENERATED
Total quantity remained unchanged
from 2010 with 51% recycled

1As defined by the World Health Organization. Burdens of illness not addressed include road traffic accidents, prematurity and low birth weight, and self-inflicted injuries.

2Program/commercial transaction defined as a Pfizer investment or dedicated contract of over $250,000 with a national government or procurement agency, MLO, NGO, private institution or aid agency. Represents multi-country initiatives only and does not include numerous local initiatives to address access.

3Represents minimum number of emerging markets with pricing tailored to different patient segments (for at least one product), allowing access for more patients.

4Represents 90% of Pfizer employees and directly-supervised contractors.

5Data are baseline adjusted, reported absolute, using reporting boundaries per the WRI GHG Protocol; and account for the King Pharmaceuticals acquisition and Capsugel divestiture. Expanded environmental reporting will be posted on www.pfizer.com later this year.

6Total direct and indirect emissions (including fleet and aviation). Does not include Scope 3 emissions.

7In 2011, Pfizer adopted the Global Reporting Initiative (GRI) indicators for water, discontinuing previously reported self-defined "Net Water Use" KPI.

8Quantity of non-hazardous waste decreased by 9% compared to 2010 while the quantity of hazardous waste increased by 3%.